ArticleBioengineering (Basel, Switzerland)2025
Deep Learning for Pathology: YOLOv8 with EigenCAM for Reliable Colorectal Cancer Diagnostics.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Explainable Computational Imaging for Precision Oncology: An Interpretable Deep Learning Framework for Bladder Cancer Histopathology Diagnosis.Bioengineering (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer (CRC) is one of the most common causes of cancer-related deaths globally, making a timely and reliable diagnosis essential. Manual histopathology assessment, though clinically standard, is prone to observer variability, while existing computational approaches often trade accuracy for interpretability, limiting their clinical utility. This paper introduces a deep learning framework that couples the YOLOv8 architecture for multiclass lesion classification with EigenCAM for transparent model explanations. The pipeline integrates three core stages: (i) acquisition and preprocessing of 5000 hematoxylin-and-eosin-stained slides from the University Medical Center Mannheim, categorized into eight tissue types; (ii) comparative evaluation of five YOLOv8 variants (Nano, Small, Medium, Large, XLarge); and (iii) interpretability through EigenCAM visualizations to highlight discriminative regions driving predictions. Extensive statistical validation (including box plots, empirical cumulative distribution functions, Bland-Altman plots, and pair plots) demonstrated the robustness and reliability of the framework. The YOLOv8 XLarge model achieved 99.38% training accuracy and 96.62% testing accuracy, outperforming recent CNN- and Transformer-based systems (≤95%). This framework establishes a clinically dependable foundation for AI-assisted CRC diagnosis by uniting high precision with visual interpretability. It represents a significant step toward real-world deployment in pathology workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.